Medication overuse headache: The effectivity of iv lidocaine - magnesium

dc.authorid0000-0003-4148-2539en_US
dc.contributor.authorTepe, Nermin
dc.contributor.authorTertemiz, Oktay Faysal
dc.date.accessioned2022-06-02T08:22:18Z
dc.date.available2022-06-02T08:22:18Z
dc.date.issued2021en_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.descriptionTepe, Nermin (Balikesir Author)en_US
dc.description.abstractThe detoxification process in medication overuse headache is the most difficult process for the patient. We aimed to investigate the effectiveness of the combination of low dose IV lidocaine and magnesium (100 mg lidocaine and 1.25 mg magnesium) in patients with medication overuse headache during the detoxification process. A total of 30 patients were included in the study; 15 received 24 hours of IV hydration, 15 received 1-hour lidocaine-magnesium infusion at the onset of pain in addition to the 24 hours of IV hydration. Headache severity (numeric rating scale, NRS), attack durations, onset of headache, monthly analgesic/triptan intakes, numbers of monthly headache days data were documented. We evaluated the severity of headache before and after daily treatment of two groups for one week. When both groups were compared, there was no significant difference in the pre-treatment NRS values, whe­reas, in the group receiving IV lidocaine-magnesium combination, there was a statistically significant decrease in the post-treatment NRS values in the first five days (p <0.05). An 1-hour combined infusion of lidocaine-magnesium may be considered as an alternative option for the patient to have a more quality detoxification process during the hospital stay, so that in parallel to the reduction in the use of multiple treatments (such as neuroleptics, benzodiazepines, antiemetics and opioids) and duration length of stay, the economic costs can also be reduced. The administration of combination will bring fewer side effects compared to their administration separately.en_US
dc.identifier.doi10.18071/isz.74.0323
dc.identifier.endpage328en_US
dc.identifier.issn0019-1442
dc.identifier.issn2498-6208
dc.identifier.issue9-10en_US
dc.identifier.scopus2-s2.0-85117303388
dc.identifier.scopusqualityQ4
dc.identifier.startpage323en_US
dc.identifier.urihttps://doi.org/10.18071/isz.74.0323
dc.identifier.urihttps://hdl.handle.net/20.500.12462/12305
dc.identifier.volume74en_US
dc.identifier.wosWOS:000752218100003
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherLiteratura Medicaen_US
dc.relation.ispartofIdeggyogyaszati Szemle-Clinical Neuroscienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHeadacheen_US
dc.subjectMagnesiumen_US
dc.subjectLidocaineen_US
dc.subjectNumeric Rating Scalesen_US
dc.subjectDetoxificationen_US
dc.titleMedication overuse headache: The effectivity of iv lidocaine - magnesiumen_US
dc.typeArticleen_US

Dosyalar

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: